KVUE:NYSE
Kenvue Inc
17,90 USD
arrow_upward
+0,82%(+0,15) 1D
14. lis, 13:02:04 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za KVUE...
Otvori
17,92 USD
Najviša
18,04 USD
Najniža
17,76 USD
Trž. kap.
34,40 mlr.
Prosj. kol.
24,20 mil.
Količina
12,54 mil.
Dividenda
4,69 %
Kvartalna dividenda
0,21 USD
Datum nakon isplate dividende
21. ruj 2026.
P/E omjer
20,76
52-tjed. najviša
20,13 USD
52-tjed. najniža
14,02 USD
EPS
0,86 USD
Beta
0,48
Dionice u optjecaju
1,92 mlr.
Broj djelatnika
22 tis.
Otvori
17,92 USD
Najviša
18,04 USD
Najniža
17,76 USD
Trž. kap.
34,40 mlr.
Prosj. kol.
24,20 mil.
Količina
12,54 mil.
Dividenda
4,69 %
Kvartalna dividenda
0,21 USD
Datum nakon isplate dividende
21. ruj 2026.
P/E omjer
20,76
52-tjed. najviša
20,13 USD
52-tjed. najniža
14,02 USD
EPS
0,86 USD
Beta
0,48
Dionice u optjecaju
1,92 mlr.
Broj djelatnika
22 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Reuters
·
prije 1 dan
EU approves Kimberly-Clark's $40 billion Kenvue acquisition
News Corp
·
prije 1 dan
Kimberly-Clark, Kenvue Win Conditional EU Approval for $40 Billion Tie-Up
Investing.com South Africa
·
prije 1 dan
Kimberly-Clark wins EU approval for Kenvue acquisition By Investing.com
Profil
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index.
CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
Kenvue Inc – informacije
Glavni izvršni direktorKirk Perry
Zaposlenici21,9 tis.
Osnovano2022
SjedišteSummit, New Jersey, Sjedinjene Američke Države
SektorPersonal care products
Web-lokacijakenvue.com